TEX264 Activators
TEX264 Activators are chemical compounds that influence specific cellular processes and signaling pathways that indirectly enhance the functional activity of TEX264. TEX264 is intricately involved in the endoplasmic-reticulum-associated protein degradation (ERAD) pathway, which is crucial for the degradation of misfolded proteins in the ER. Compounds like Epoxomicin, MG132, and Bortezomib are proteasome inhibitors that lead to the accumulation of ubiquitinated proteins, thereby increasing the demand for the ERAD process, where TEX264's activity is essential. ER stress inducers like Tunicamycin and Thapsigargin disrupt proper folding and glycosylation of proteins, triggering the unfolded protein response (UPR) and consequently enhancing the ERAD pathway and the activity of TEX264.
Furthermore, compounds such as Eeyarestatin I, which inhibits the p97 ATPase, and Radicicol, which targets Hsp90, can disrupt the normal degradation and folding processes within the ER, leading to a buildup of misfolded proteins. This accumulation presses for a more robust ERAD response, in which TEX264plays a crucial role. Other chemicals, such as Chloroquine and Salubrinal, inhibit autophagy and the dephosphorylation of eIF2α, respectively, both of which can lead to enhanced ER stress. This stress, in turn, could upregulate ERAD pathway components, including TEX264, to restore cellular homeostasis. Additionally, Guanabenz's ability to enhance the integrated stress response (ISR) indirectly supports the functional activity of TEX264 by promoting mechanisms that deal with ER stress. ML348 and 17-AAG, which inhibit APT1 and Hsp90, respectively, result in altered protein trafficking and destabilization of proteins that require the ERAD pathway, thus increasing the activity of TEX264 in this context.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Epoxomicin is a selective proteasome inhibitor that can lead to the accumulation of ubiquitinated proteins, which may require enhanced endoplasmic-reticulum-associated protein degradation (ERAD), where TEX264 is a critical effector. The increased demand for ERAD could indirectly enhance the functional activity of TEX264. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a peptide aldehyde that inhibits the proteasome and calpains. This inhibition can increase the load of misfolded proteins in the ER, indirectly enhancing the activity of TEX264 as part of the ERAD pathway to restore proteostasis. | ||||||
Eeyarestatin I | 412960-54-4 | sc-358130B sc-358130 sc-358130A sc-358130C sc-358130D sc-358130E | 5 mg 10 mg 25 mg 50 mg 100 mg 500 mg | $114.00 $203.00 $354.00 $697.00 $1363.00 $5836.00 | 12 | |
Eeyarestatin I is an inhibitor of the p97 ATPase and ERAD. It disrupts the degradation of ERAD substrates, potentially enhancing the requirement for TEX264's function in the ERAD pathway to compensate for the inhibition of p97. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, causing ER stress and upregulating UPR targets, including components of the ERAD pathway. This could lead to increased activity of TEX264, which is involved in the ERAD process. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that induces ER stress and activates the unfolded protein response (UPR), potentially enhancing the ERAD pathway where TEX264 operates as a key effector protein. | ||||||
Radicicol | 12772-57-5 | sc-200620 sc-200620A | 1 mg 5 mg | $92.00 $333.00 | 13 | |
Radicicol binds to Hsp90, inhibiting its chaperone activity, which can lead to the aggregation of misfolded proteins in the ER and potentially increase the activity of TEX264 in the ERAD pathway. | ||||||
Chloroquine Sulphate | 132-73-0 | sc-337629 | 25 mg | $224.00 | 2 | |
Chloroquine is an autophagy inhibitor that can lead to the accumulation of autophagosomes. This could indirectly enhance the activity of TEX264, which is implicated in ER-phagy, a selective form of autophagy. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $34.00 $104.00 | 87 | |
Salubrinal is a selective inhibitor of eIF2α dephosphorylation, leading to increased eIF2α phosphorylation and an enhanced integrated stress response (ISR), potentially upregulating TEX264 as part of the ER stress response. | ||||||
Guanabenz acetate | 23256-50-0 | sc-203590 sc-203590A sc-203590B sc-203590C sc-203590D | 100 mg 500 mg 1 g 10 g 25 g | $102.00 $468.00 $832.00 $4162.00 $7283.00 | 2 | |
Guanabenz is an alpha-2 adrenergic receptor agonist known to enhance the ISR by inhibiting eIF2α dephosphorylation. This can indirectly enhance the functionality of TEX264 in coping with ER stress. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
17-AAG is an Hsp90 inhibitor that can destabilize client proteins and increase the need for cellular quality control mechanisms, including ERAD, where TEX264 is functionally active. | ||||||